BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 19175716)

  • 41. A phase I study of pemetrexed, carboplatin, and concurrent radiotherapy in patients with locally advanced or metastatic non-small cell lung or esophageal cancer.
    Seiwert TY; Connell PP; Mauer AM; Hoffman PC; George CM; Szeto L; Salgia R; Posther KE; Nguyen B; Haraf DJ; Vokes EE
    Clin Cancer Res; 2007 Jan; 13(2 Pt 1):515-22. PubMed ID: 17255273
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Suspected Carboplatin Extravasation Reactions in Seven Dogs.
    Miller KB; Lejeune A; Regan R; Szivek A; Kow K
    J Am Anim Hosp Assoc; 2018; 54(6):360-367. PubMed ID: 30272477
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy and safety of the combination paclitaxel/carboplatin in patients with previously treated advanced ovarian carcinoma: a multicenter French Groupe des Investigateurs Nationaux pour l'Etude des Cancers Ovariens phase II study.
    Pujade-Lauraine E; Guastalla JP; Weber B; Curé H; Orfeuvre H; Mousseau M; Vincent P; Diéras V; Tubiana-Mathieu N; Jacquin JP; Mignot L; Leduc B; Paraïso D; Viens P
    Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-30-S15-35. PubMed ID: 9346219
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of toxicities from combined metronomic and maximal-tolerated dose chemotherapy in dogs with osteosarcoma.
    Bracha S; Walshaw R; Danton T; Holland S; Ruaux C; Obradovich J
    J Small Anim Pract; 2014 Jul; 55(7):369-74. PubMed ID: 24803081
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Toxicoses associated with the administration of mitoxantrone to dogs with malignant tumors: a dose escalation study.
    Ogilvie GK; Moore AS; Chen C; Ciekot PA; Atwater SW; Bergman PJ; Walters LM
    J Am Vet Med Assoc; 1994 Aug; 205(4):570-3. PubMed ID: 7961092
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inductively coupled plasma mass-spectrometric determination of platinum in excretion products of client-owned pet dogs.
    Janssens T; Brouwers EE; de Vos JP; de Vries N; Schellens JH; Beijnen JH
    Vet Comp Oncol; 2015 Jun; 13(2):124-32. PubMed ID: 23714139
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Standard thoracic radiotherapy with or without concurrent daily low-dose carboplatin in elderly patients with locally advanced non-small cell lung cancer: a phase III trial of the Japan Clinical Oncology Group (JCOG9812).
    Atagi S; Kawahara M; Tamura T; Noda K; Watanabe K; Yokoyama A; Sugiura T; Senba H; Ishikura S; Ikeda H; Ishizuka N; Saijo N;
    Jpn J Clin Oncol; 2005 Apr; 35(4):195-201. PubMed ID: 15845568
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Carboplatin/paclitaxel versus cisplatin/paclitaxel as first-line chemotherapy in advanced ovarian cancer: an interim analysis of a randomized phase III trial of the Arbeitsgemeinschaft Gynäkologische Onkologie Ovarian Cancer Study Group.
    du Bois A; Lück HJ; Meier W; Möbus V; Costa S; Richter B; Warm M; Bauknecht T; Schröder W; Olbricht S; Nitz U; Jackisch C
    Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-44-S15-52. PubMed ID: 9346222
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Induction therapy with carboplatin/paclitaxel followed by concurrent carboplatin/paclitaxel and dose-escalating conformal radiotherapy in the treatment of locally advanced, unresectable non-small cell lung cancer: preliminary report of a phase I trial.
    Socinski MA; Clark JA; Halle J; Steagall A; Kaluzny B; Rosenman JG
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-117-S12-122. PubMed ID: 9331135
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Phase I clinical trial of weekly paclitaxel, weekly carboplatin, and concurrent radiotherapy for primary cervical cancer.
    Rao GG; Rogers P; Drake RD; Nguyen P; Coleman RL
    Gynecol Oncol; 2005 Jan; 96(1):168-72. PubMed ID: 15589596
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intensity-modulated and image-guided radiation therapy for treatment of genitourinary carcinomas in dogs.
    Nolan MW; Kogan L; Griffin LR; Custis JT; Harmon JF; Biller BJ; Larue SM
    J Vet Intern Med; 2012; 26(4):987-95. PubMed ID: 22624845
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Carboplatin.
    Fox LE
    J Am Anim Hosp Assoc; 2000; 36(1):13-4. PubMed ID: 10667400
    [No Abstract]   [Full Text] [Related]  

  • 53. Severe, prolonged bone marrow hypoplasia secondary to the use of carboplatin in an azotemic dog.
    Phillips B
    J Am Vet Med Assoc; 1999 Nov; 215(9):1250-2; discussion 1252-3. PubMed ID: 10553432
    [No Abstract]   [Full Text] [Related]  

  • 54. A phase I trial of carboplatin and etoposide for elderly (>or=75 year-old) patients with small-cell lung cancer.
    Fukuda M; Soda H; Soejima Y; Fukuda M; Kinoshita A; Takatani H; Kasai T; Nagashima S; Kawabata S; Doi S; Kohno S; Oka M
    Cancer Chemother Pharmacol; 2006 Nov; 58(5):601-6. PubMed ID: 16463061
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Malignant melanoma in 63 dogs (2001-2011): the effect of carboplatin chemotherapy on survival.
    Brockley LK; Cooper MA; Bennett PF
    N Z Vet J; 2013 Jan; 61(1):25-31. PubMed ID: 22913610
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A phase II study of concurrent carboplatin and paclitaxel and thoracic radiotherapy for completely resected stage II and IIIA non-small cell lung cancer.
    Feigenberg SJ; Hanlon AL; Langer C; Goldberg M; Nicolaou N; Millenson M; Coia LR; Lanciano R; Movsas B
    J Thorac Oncol; 2007 Apr; 2(4):287-92. PubMed ID: 17409799
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Supporting the veterinary cancer patient on chemotherapy: neutropenia and gastrointestinal toxicity.
    Vail DM
    Top Companion Anim Med; 2009 Aug; 24(3):122-9. PubMed ID: 19732730
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Paclitaxel by 24- or 1-hour infusion n combination with carboplatin in advanced non-small cell lung cancer: the Fox Chase Cancer Center experience.
    Langer CJ; Leighton JC; Comis RL; O'Dwyer PJ; McAleer CA; Bonjo CA; Engstrom PF; Litwin S; Johnson S; Ozols RF
    Semin Oncol; 1995 Aug; 22(4 Suppl 9):18-29. PubMed ID: 7544025
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Risk factors for treatment-related adverse events in cancer-bearing dogs receiving piroxicam.
    Eichstadt LR; Moore GE; Childress MO
    Vet Comp Oncol; 2017 Dec; 15(4):1346-1353. PubMed ID: 27714960
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neutropenia in dogs receiving vincristine for treatment of presumptive immune-mediated thrombocytopenia.
    LaQuaglia KA; Robertson JB; Lunn KF
    J Vet Intern Med; 2021 Jan; 35(1):226-233. PubMed ID: 33421218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.